PAHC Phibro Animal Health Corp

Price (delayed)

$20.3

Market cap

$822.22M

P/E Ratio

14

Dividend/share

$0.48

EPS

$1.45

Enterprise value

$1.17B

Phibro Animal Health Corporation is a diversified global developer, manufacturer and supplier of a broad range of animal health and mineral nutrition products for livestock, helping veterinarians and farmers produce ...

Highlights
PAHC's P/E is 37% below its 5-year quarterly average of 22.1 and 19% below its last 4 quarters average of 17.2
PAHC's net income is up by 37% year-on-year and by 10% since the previous quarter
PAHC's debt is up by 9% YoY and by 3.8% QoQ
The quick ratio has decreased by 7% from the previous quarter

Key stats

What are the main financial stats of PAHC
Market
Shares outstanding
40.5M
Market cap
$822.22M
Enterprise value
$1.17B
Valuations
Price to earnings (P/E)
14
Price to book (P/B)
3.08
Price to sales (P/S)
0.91
EV/EBIT
13.15
EV/EBITDA
9.65
EV/Sales
1.29
Earnings
Revenue
$907.27M
EBIT
$88.77M
EBITDA
$120.92M
Free cash flow
$897,000
Per share
EPS
$1.45
Free cash flow per share
$0.02
Book value per share
$6.59
Revenue per share
$22.4
TBVPS
$19.64
Balance sheet
Total assets
$916.18M
Total liabilities
$649.24M
Debt
$415.62M
Equity
$266.95M
Working capital
$359.38M
Liquidity
Debt to equity
1.56
Current ratio
2.92
Quick ratio
1.33
Net debt/EBITDA
2.85
Margins
EBITDA margin
13.3%
Gross margin
30.5%
Net margin
6.5%
Operating margin
8.3%
Efficiency
Return on assets
6.8%
Return on equity
24.1%
Return on invested capital
9.6%
Return on capital employed
12.2%
Return on sales
9.8%
Dividend
Dividend yield
2.36%
DPS
$0.48
Payout ratio
33.1%

PAHC stock price

How has the Phibro Animal Health stock price performed over time
Intraday
7.07%
1 week
11.78%
1 month
9.73%
1 year
-30.29%
YTD
-0.59%
QTD
1.75%

Financial performance

How have Phibro Animal Health's revenue and profit performed over time
Revenue
$907.27M
Gross profit
$276.8M
Operating income
$75.26M
Net income
$58.81M
Gross margin
30.5%
Net margin
6.5%
PAHC's net income is up by 37% year-on-year and by 10% since the previous quarter
PAHC's net margin is up by 20% YoY and by 7% QoQ
The revenue has increased by 14% year-on-year and by 3.2% since the previous quarter
The operating margin has declined by 10% year-on-year and by 4.6% since the previous quarter

Growth

What is Phibro Animal Health's growth rate over time

Valuation

What is Phibro Animal Health stock price valuation
P/E
14
P/B
3.08
P/S
0.91
EV/EBIT
13.15
EV/EBITDA
9.65
EV/Sales
1.29
PAHC's P/E is 37% below its 5-year quarterly average of 22.1 and 19% below its last 4 quarters average of 17.2
PAHC's EPS is up by 37% year-on-year and by 11% since the previous quarter
PAHC's P/B is 49% below its 5-year quarterly average of 6.0 and 19% below its last 4 quarters average of 3.8
The equity is up by 24% year-on-year and by 12% since the previous quarter
The stock's price to sales (P/S) is 35% less than its 5-year quarterly average of 1.4 and 17% less than its last 4 quarters average of 1.1
The revenue has increased by 14% year-on-year and by 3.2% since the previous quarter

Efficiency

How efficient is Phibro Animal Health business performance
Phibro Animal Health's ROA has increased by 26% YoY and by 6% from the previous quarter
The return on equity is up by 14% year-on-year and by 4.8% since the previous quarter
The ROIC has increased by 8% from the previous quarter and by 5% YoY
PAHC's return on sales is up by 8% since the previous quarter

Dividends

What is PAHC's dividend history
DPS
$0.48
Dividend yield
2.36%
Payout ratio
33.1%
Recent dividends

Financial health

How did Phibro Animal Health financials performed over time
Phibro Animal Health's total assets is 41% higher than its total liabilities
Phibro Animal Health's total assets has increased by 14% YoY and by 8% QoQ
The total liabilities rose by 10% year-on-year and by 6% since the previous quarter
PAHC's debt is 56% higher than its equity
The equity is up by 24% year-on-year and by 12% since the previous quarter
PAHC's debt to equity is down by 11% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.